MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » FDA: CareFusion’s Avea ventilator recall is Class I

FDA: CareFusion’s Avea ventilator recall is Class I

By

CareFusion recalls Avea ventilators

CareFusion said it’s recalling all of its Avea ventilators over a possible pressure transducer failure that may cause the units to stop functioning.

A failure in the pressure transducer can lead to a false alarm in the device, which causes the units to stop ventilating, the company said. The failure resulted in a Class I status from the FDA, which denotes a risk of serious injury or death. No deaths or major injuries have been reported so far, CareFusion said.

A total of 15,905 units worldwide are affected by the recall, with 5,670 units in the U.S., according to the FDA. The devices under recall were manufactured between July 1, 2011, and March 15.

A letter informing customers to contact the the San Diego-based company is being sent to all customers who own an Avea ventilator, CareFusion said. The company is also coordinating on-site ventilator corrections with customers.

CareFusion was purchased by Franklin Lakes, N.J.-based Becton Dickinson (NYSE:BDX) in a $12.2 billion deal that closed in March.

In case you missed it

RSS From Medical Design & Outsourcing

  • Could this hydrogel repair damaged nerves?
    Researchers in China are touting a hydrogel that could be used to repair certain damaged nerves one day. Qun-Dong Shen, Chang-Chun Wang, Ze-Zhang Zhu and colleagues are developing a stretchable, conductive hydrogel in an effort to find a method for repairing peripheral nerves that, when damaged, result in chronic pain, neurologic disorders, paralysis or disability.… […]
  • Stryker launches a smart hospital bed
    Stryker (NYSE:SYK) announced this week that it launched the ProCuity wireless smart hospital bed to improve efficiency and safety while lowering costs. The intelligent bed was designed to help reduce in-hospital patient falls at all acuity levels while also improving nurse workflow efficiencies and safeties at lesser cost to the hospital. Stryker said in a news… […]
  • West Pharmaceuticals dips despite strong Q3, raised guidance
    West Pharmaceutical Services (NYSE:WST) shares dipped slightly despite third-quarter results that topped the consensus forecast. The Exton, Pa.-based company posted profits of $82.3 million, or $1.09 per share, on sales of $548 million for the three months ended Sept. 30, 2020, for a 46.2% bottom-line gain on sales growth of 0.3%. Get the full story at… […]
  • Level Ex builds virtual bridge to span medical device divide
    With COVID-19 shutting down clinical meetings and closing operating room doors to sales reps, medical device manufacturers are searching for new ways to support surgeons and physicians using their devices. Level Ex, maker of a video game system, this week shared how it will help bridge this device divide, rolling out its Virtual Technique Guides,… […]
  • Interpower to produce Virtual Global Trade Show Booth
    Interpower (Oskaloosa, Iowa) — an electrical power cord and component manufacturer — plans to launch its Virtual Trade Show Booth on Oct. 27. The idea is to connect with its customers as well as industry professionals. This Virtual Booth launch comes after a year of quarantines and travel restrictions which prompted show postponements and cancellations.… […]
  • Are Stephen Hahn’s days numbered at FDA?
    HHS Secretary Alex Azar has been reportedly discussing the removal of Dr. Stephen Hahn as FDA commissioner, according to Politico. The Politico report cited a half dozen current and former administration officials. FDA spokesperson Michael Felberbaum in an email to Medical Design & Outsourcing‘s sister site MassDevice denied an Azar-Hahn feud: “Commissioner Hahn enjoys a… […]
  • Applied VR gains FDA breakthrough device nod
    AppliedVR announced that it received FDA breakthrough device designation for its fibromyalgia and lower back pain treatment. Los Angeles-based AppliedVR’s EaseVRx product is designed to treat treatment-resistant fibromyalgia and chronic intractable lower back pain. With the breakthrough nod, EaseVRx is now one of the first virtual reality (VR) digital therapeutics to earn that designation for… […]
  • DeviceTalks Tuesdays: Creativity in Engineering Design: Things I Was Never Taught In Engineering School
    Tuesday, Oct. 27, 2020 4 pm Eastern Tim/ 1 pm Pacific Time Engineering is an act of creation – a lot of folks get into this line of work explicitly because they want to create. In this webinar, speakers will talk about the light bulb moments of lone inspiration, and the more practical group efforts.… […]
  • Acuitive Technologies wins FDA clearance for tendon interference screw system
    Acuitive Technologies announced today that it received FDA 510(k) clearance for its CitreLock interference screw system. CitreLock with CitreGen material technology, a next-generation thermoset bioresorbable synthetic polymer, is designed to attach tissue during orthopedic surgeries, including the fixation of ligaments or tendon graft tissue repairs of the shoulder, elbow, wrist, hand, knee and foot extremities,… […]
  • Medovate lands distro deal with major French medtech company
    Medtech manufacturer Vygon Group recently announced that it will distribute Medovate’s SAFIRA (SAFer Injection for Regional Anaesthesia) device across 60 countries. Developed in collaboration with UK National Health Service clinicians, SAFIRA is designed to transform the technique of peripheral nerve blockade into a one-person procedure, giving the anaesthetist full control of the injection at all… […]
  • How spider webs could inspire better biomedical imaging
    Researchers at Purdue University are today touting the use of architectural features from spider webs in biomedical imaging. As spider webs usually provide strong mechanical adaptability and damage-tolerance against various mechanical loads, such as storms, they are coming in handy in the development of 3D photodetectors for use in biomedical imaging, according to a news… […]

Leave a Reply